Download DNB 2020 December SurgIcal Oncology Paper II Question Paper

Download Diplomate of National Board (DNB) 2020 December SurgIcal Oncology Paper II Question Paper

FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2020
SURGICAL ONCOLOGY
PAPER-II
Time: 3 hours
SURGONCO/D/20/47/II
Max. Marks:100
Important Instructions:
You are provided with 5 answer sheet booklets. Each individual answer sheet booklet consists
of 10 pages excluding the covering jackets.
Answers to all the questions must be attempted within these 5 answer sheet booklets which
must be later tagged together at the end of the exam.
No additional supplementary answer sheet booklet will be provided.
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/flowcharts wherever appropriate.

Write short notes on:

1. a) General principles in neoadjuvant therapy in rectal cancers.
5+5
b) Role of neo-adjuvant therapy in sphincter salvage.
2. a) What are the risk factors for endometrial cancers?
2+3+5
b) Molecular based classification of endometrial carcinoma.
c) Current evidence for minimal invasive surgery for carcinoma
endometrium.
3. a) Significance of HPV in head and neck cancers.
5+5
b) Difference in management and outcomes of HPV related squamous cell
carcinomas (HNSCC) of head and neck as compared to non HPV-
HNSCC.
4. Discuss Broncho-pulmonary segments. Write the current TNM staging for 3+3+4
lung cancer. Discuss the adjuvant treatment for a patient who underwent
surgery with tumor size 5 cms and a single N1 positive node.
5. a) Staging systems of Hepatoblastoma.
4+6
b) Management of Hepatoblastoma in Pediatric populations.
6. Work-up and management of carcinoma of an unknown primary.
5+5
7. a) Current status of tools available for risk assessment for adjuvant
5+5
therapy following surgery in breast cancer.
b) Assessment and work up of an asymptomatic 32 year old sister of a 35
year old patient with history of breast cancer in mother.
8. a) Discuss the options for limb salvage in a patient with locally advanced
synovial sarcoma of lower limb.
5+5
b) Briefly describe the options and factors affecting the management
decision for patient of synovial sarcoma presenting with a
metachronous pulmonary metastasis.
P.T.O.
-1-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2020
SURGICAL ONCOLOGY
PAPER-II
9. a) Mandibular reconstruction.
5+5
b) Management of anastomotic leak following esophagectomy.

10. a) Indications and regimes of chemotherapy for testicular tumors.
5+5
b) Types and indications of RPLND.
*************
-2-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.

This post was last modified on 31 July 2021